People · Operator
Named in public records as an officer, director or promoter · active 2025–2025 · Pharma
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| RenaBio Therapeutics, Inc. | — | Pharma | Seed | $1.3M | $852K | 2025 |
Hans Bitter at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Hans Bitter on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Zhenghua Wang | 1 | 1 |
| Yu (Zoe) Zhang | 1 | 1 |
| Jafari Mousa | 1 | 1 |
| Shengjun Ren | 1 | 1 |
| Ren Shengjun | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.